Company intelligence / Profile preview

TD Veen

Stavanger, Norway

Ownership: Private
Development stage: Other

Overview

TD Veen is a family-owned investment company based in Norway, focused on impact investing aligned with UN Sustainable Development Goals. They invest in Norwegian and international companies across circularity, food, health, and technology sectors. Their notable health investments include biotech venture capital firm p53, pharma tech platform Arctoris, ketamine psychotherapy provider Axon Clinic, and immunotherapy company Nykode Therapeutics.

Industry: Investors

Beyond the preview

Go deeper on TD Veen.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on TD Veen.

Explore the full profile